These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27730082)

  • 21. Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers.
    Malkan UY; Gunes G; Corakci A
    Springerplus; 2015; 4():587. PubMed ID: 26543722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative associations of diabetes risk factors with five measures of hyperglycemia.
    Poon AK; Juraschek SP; Ballantyne CM; Steffes MW; Selvin E
    BMJ Open Diabetes Res Care; 2014; 2(1):e000002. PubMed ID: 25452853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1,5-anhydroglucitol as a useful marker for assessing short-term glycemic excursions in type 1 diabetes.
    Seok H; Huh JH; Kim HM; Lee BW; Kang ES; Lee HC; Cha BS
    Diabetes Metab J; 2015 Apr; 39(2):164-70. PubMed ID: 25922811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of leukocyte count with varying degrees of glucose intolerance in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-26).
    Gokulakrishnan K; Deepa R; Sampathkumar R; Balasubramanyam M; Mohan V
    Metab Syndr Relat Disord; 2009 Jun; 7(3):205-10. PubMed ID: 19284318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes.
    Won JC; Park CY; Park HS; Kim JH; Choi ES; Rhee EJ; Lee WY; Oh KW; Kim SW; Park SW
    Diabetes Res Clin Pract; 2009 Apr; 84(1):51-7. PubMed ID: 19187997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker.
    Buse JB; Freeman JL; Edelman SV; Jovanovic L; McGill JB
    Diabetes Technol Ther; 2003; 5(3):355-63. PubMed ID: 12828817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.
    Mula-Abed WA; Al-Naemi AH
    Saudi Med J; 2003 May; 24(5):477-84. PubMed ID: 12847621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of the value of glycated hemoglobin HbA
    Kowalczuk-Wieteska AM; Wróbel M; Rokicka D; Szymborska-Kajanek A; Foremny J; Nadziakiewicz P; Zembala M; Strojek K
    Kardiochir Torakochirurgia Pol; 2016 Dec; 13(4):305-308. PubMed ID: 28096825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1,5-Anhydroglucitol in diabetes mellitus.
    Kim WJ; Park CY
    Endocrine; 2013 Feb; 43(1):33-40. PubMed ID: 22847316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1,5-Anhydroglucitol as a Marker of Acute Hyperglycemia in Cardiovascular Events.
    Migała M; Chałubińska-Fendler J; Zielińska M
    Rev Diabet Stud; 2022 Jun; 18(2):68-75. PubMed ID: 35831937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dispersion of serum 1,5 anhydroglucitol values in patients with type 2 diabetes at goal of HbA1c.
    Villena Chávez JE; Neira Sánchez ER; Poletti Ferrara LF
    Diabetes Res Clin Pract; 2023 May; 199():110668. PubMed ID: 37061006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions.
    Dungan KM
    Expert Rev Mol Diagn; 2008 Jan; 8(1):9-19. PubMed ID: 18088226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A diabetes risk score helps identify metabolic syndrome and cardiovascular risk in Indians - the Chennai Urban Rural Epidemiology Study (CURES-38).
    Mohan V; Sandeep S; Deepa M; Gokulakrishnan K; Datta M; Deepa R
    Diabetes Obes Metab; 2007 May; 9(3):337-43. PubMed ID: 17391160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum 1,5-anhydroglucitol level as a screening tool for diabetes mellitus in a community-based population at high risk of diabetes.
    Wang Y; Yuan Y; Zhang Y; Lei C; Zhou Y; He J; Sun Z
    Acta Diabetol; 2017 May; 54(5):425-431. PubMed ID: 27896445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on biomarkers of glycemic control.
    Krhač M; Lovrenčić MV
    World J Diabetes; 2019 Jan; 10(1):1-15. PubMed ID: 30697366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1,5-anhydroglucitol.
    Yamanouchi T; Moromizato H; Shinohara T; Minoda S; Miyashita H; Akaoka I
    Metabolism; 1992 Aug; 41(8):862-7. PubMed ID: 1640864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.
    Miyazaki Y; Pipek R; Mandarino LJ; DeFronzo RA
    Int J Obes Relat Metab Disord; 2003 Jan; 27(1):88-94. PubMed ID: 12532159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidized low-density lipoprotein and intimal medial thickness in subjects with glucose intolerance: the Chennai Urban Rural Epidemiology Study-25.
    Gokulakrishnan K; Deepa R; Velmurugan K; Ravikumar R; Karkuzhali K; Mohan V
    Metabolism; 2007 Feb; 56(2):245-50. PubMed ID: 17224340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome--the Chennai Urban Rural Epidemiology Study.
    Gokulakrishnan K; Deepa R; Mohan V; Gross MD
    Metabolism; 2006 Feb; 55(2):237-42. PubMed ID: 16423632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Mellitus and CKD.
    Presswala L; Hong S; Harris Y; Romao I; Zhang M; Jhaveri KD; Sakhiya V; Fishbane S
    Kidney Med; 2019; 1(5):281-287. PubMed ID: 32734208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.